SC 13G
RELMADA THERAPEUTICS, INC.
- Company
- RELMADA THERAPEUTICS, INC.
- Filed
- October 17, 2022
- Accession Number
- 0001104659-22-109334
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →